Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
PUT
Coherent
COHR
$74.2B
| $456K | ﹤0.01% |
13,300
+12,700
| +2,117% | +$411K |
|
3577
PUT
Park Hotels & Resorts
PK
$2.97B
| $456K | ﹤0.01% |
16,918
-2,332
| -12% | -$61.7K |
|
|
GOV
3578
DELISTED
Government Properties Income Trust
GOV
| $456K | ﹤0.01% |
24,894
-78,613
| -76% | -$1.71M |
|
|
SEM
3579
DELISTED
Select Medical
SEM
| $455K | ﹤0.01% |
55,049
+50,689
| +1,163% | +$380K |
|
|
KND
3580
DELISTED
Kindred Healthcare
KND
| $453K | ﹤0.01% |
38,861
-115,270
| -75% | -$1.14M |
|
|
IIF
3581
Morgan Stanley India Investment Fund
IIF
$220M
| $451K | ﹤0.01% |
13,922
-2,500
| -15% | -$82.9K |
|
3582
Argan
AGX
$8.37B
| $450K | ﹤0.01% |
7,498
+431
| +6% | +$27.8K |
|
3583
Hexcel
HXL
$7.82B
| $450K | ﹤0.01% |
8,521
-21,538
| -72% | -$1.11M |
|
3584
Zumiez
ZUMZ
$339M
| $450K | ﹤0.01% |
36,382
-18,766
| -34% | -$287K |
|
3585
Alliance Resource Partners
ARLP
$3.17B
| $449K | ﹤0.01% |
23,731
-121
| -0.5% | -$2.62K |
|
|
TGI
3586
DELISTED
Triumph Group
TGI
| $449K | ﹤0.01% |
14,205
+6,443
| +83% | +$179K |
|
|
USCR
3587
DELISTED
U S Concrete, Inc.
USCR
| $448K | ﹤0.01% |
5,700
-5,652
| -50% | -$384K |
|
3588
ICU Medical
ICUI
$4.61B
| $447K | ﹤0.01% |
2,588
-1,196
| -32% | -$192K |
|
3589
PUT
IMAX
IMAX
$2.66B
| $447K | ﹤0.01% |
20,300
+20,100
| +10,050% | +$564K |
|
3590
PUT
Opko Health
OPK
$1.02B
| $447K | ﹤0.01% |
68,000
+25,000
| +58% | +$175K |
|
3591
PUT
ProShares Ultra S&P500
SSO
$8.41B
| $447K | ﹤0.01% |
40,000
-256,800
| -87% | -$2.81M |
|
3592
PUT
BCE
BCE
$21.2B
| $446K | ﹤0.01% |
9,900
-2,200
| -18% | -$99.2K |
|
3593
Rigel Pharmaceuticals
RIGL
$750M
| $446K | ﹤0.01% |
16,317
+13,113
| +409% | +$359K |
|
3594
Federal Agricultural Mortgage
AGM
$2.56B
| $445K | ﹤0.01% |
6,869
+1,320
| +24% | +$79.9K |
|
3595
AtriCure
ATRC
$2.11B
| $445K | ﹤0.01% |
18,322
-6,555
| -26% | -$139K |
|
3596
PUT
EQT Corp
EQT
$32.3B
| $445K | ﹤0.01% |
13,961
-3,858
| -22% | -$122K |
|
|
QTS
3597
CALL
DELISTED
QTS REALTY TRUST, INC.
QTS
| $445K | ﹤0.01% |
+8,500
| New | +$440K |
|
3598
Power Integrations
POWI
$3.61B
| $444K | ﹤0.01% |
12,190
+6,720
| +123% | +$223K |
|
|
AXDX
3599
PUT
DELISTED
Accelerate Diagnostics
AXDX
| $443K | ﹤0.01% |
+1,620
| New | +$439K |
|
|
EPZM
3600
DELISTED
Epizyme, Inc
EPZM
| $443K | ﹤0.01% |
29,330
+12,653
| +76% | +$191K |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.